Biolase Anticipates Q1 Net Revenue To Exceed $10M, Relatively Flat Y/Y (Est $10.796M); 2024 Net Revenue To Increase 6%-8% To $52M-$53M (Est $53.068M)
Portfolio Pulse from Benzinga Newsdesk
Biolase expects its Q1 net revenue to surpass $10M, showing no significant change year-over-year, against an estimate of $10.796M. The company also forecasts a 6%-8% increase in net revenue for 2024, aiming for $52M-$53M, slightly below the estimated $53.068M.
March 21, 2024 | 8:55 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Biolase anticipates Q1 net revenue to exceed $10M, relatively unchanged from the previous year, and expects a 6%-8% revenue growth in 2024 to $52M-$53M.
Biolase's announcement of expected Q1 revenue exceeding $10M, though flat year-over-year, and a modest growth forecast for 2024, indicates a stable but cautious outlook. The slight miss against estimates may temper investor enthusiasm, leading to a neutral short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100